Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa

Ítems similars

• Long term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification
  per: Petersen, Maya L., et al.
  Publicat: (2008)
• Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
  per: Ssempijja, Victor, et al.
  Publicat: (2017)
• Early outcomes and the virologic impact of delayed treatment switching on second-line therapy in an antiretroviral roll-out program in South Africa
  per: Levison, Julie H., et al.
  Publicat: (2011)
• Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach
  per: Geng, Elvin H., et al.
  Publicat: (2010)
• The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
  per: Rosenblum, Michael, et al.
  Publicat: (2009)